OpenAlex
PricingAboutJobs
Log inGet started
Work

40P Real-world safety and effectiveness of ribociclib in Korean patients with HR+/HER2- locally advanced or metastatic breast cancer

HTML

Year: 2024
Type: article
Source: Annals of Oncology
DOI: 10.1016/j.annonc.2024.10.062
Authors: J.H. Kim, M-C. Chang, T-H. Kim, J.H. Seo, J-J. Kim, H.S. Won, M-K. Seong, Y. Kang, Y. Lee, K-H. Lee
Institutions: Yonsei University, Gangnam Severance Hospital, Pusan National University Yangsan Hospital, Yonsei University Health System, Dankook University Hospital, Ajou University, Korea University Guro Hospital, The Catholic University of Korea Uijeongbu St. Mary's Hospital, Novartis (Switzerland), Novartis (South Korea), Seoul National University, Seoul National University Hospital
Language: English

Topic: Advanced Breast Cancer Therapies
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
SDG: Good health and well-being

Open Access status: bronze

Funder: Novartis Pharmaceuticals Corporation
OpenAlex ID: W4405141682
FWCI:
Cites:
Cited by:
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms